United States Biological Revenue and Competitors
Estimated Revenue & Valuation
- United States Biological's estimated annual revenue is currently $2.8M per year.
- United States Biological's estimated revenue per employee is $155,000
Employee Data
- United States Biological has 18 Employees.
- United States Biological grew their employee count by -10% last year.
United States Biological's People
Name | Title | Email/Phone |
---|---|---|
1 | Operations Manager | Reveal Email/Phone |
2 | Database and Marketing Manager | Reveal Email/Phone |
3 | Information Technologist | Reveal Email/Phone |
4 | Customer Service Representative | Reveal Email/Phone |
United States Biological Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is United States Biological?
United States Biological Inc is a primary brand for the Life Science Industry. United States Biological's biochemicals, antibodies, recombinant proteins, cell culture media and molecular biology kits are used in virtually all scientific applications and settings, including genomic research, biotechnology, pharmaceutical development and the diagnosis of disease. Products are available from affordable research quantities to larger bulk amounts for process development and production. Our customers include most of the leading pharmaceutical and biotechnology companies located in the US and abroad.
keywords:N/AN/A
Total Funding
18
Number of Employees
$2.8M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.6M | 18 | 6% | N/A |
#2 | $1.6M | 18 | 6% | N/A |
#3 | $2.7M | 18 | -5% | N/A |
#4 | $1.6M | 18 | 6% | N/A |
#5 | $1.4M | 18 | -25% | N/A |